DENTSPLY SIRONA (XRAY) Could Be Entering 3D Printing - Piper Sandler

Piper Sandler analyst Jason Bednar reiterated an Overweight rating and $51.00 price target on DENTSPLY SIRONA (NASDAQ: XRAY) after diligence led them to uncover a trademark XRAY filed on “Primeprint” earlier this year, which, along with 3D printing-related IP also secured in recent months, leads them to believe XRAY could be entering the practice-based 3D printing market in the near future.

The analyst commented, " 3Dprinting isn’t new to dentistry, but we do believe such a launch could serve to leverage the company's strong high-tech equipment reputation, create a halo effect on the company’sPrimescan system, potentially lead to a differentiated clear aligner procedural solution for GPs, and provide incremental revenue growth tailwinds to the T&E segment. WithPrimeprint potentially further enhancing XRAY’s best-in-class CEREC offering, we reiterate our OW rating and continue to view XRAY as the name to own in dental."

For an analyst ratings summary and ratings history on DENTSPLY International click here. For more ratings news on DENTSPLY International click here.

Shares of DENTSPLY International closed at $44.60 yesterday.

You May Also Be Interested In

• Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
• BorgWarner (BWA) PT Raised to $95 at Wolfe Research, 'Bullish Takeaways from CEO Meetings'
• Bernstein SocGen Group Starts Cipher Mining (CIFR) at Outperform